TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
71.95
-3.50 (-4.64%)
At close: Feb 21, 2025, 4:00 PM
71.70
-0.25 (-0.35%)
After-hours: Feb 21, 2025, 7:57 PM EST
TransMedics Group Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for TransMedics Group stock have an average target of 116.1, with a low estimate of 75 and a high estimate of 178. The average target predicts an increase of 61.36% from the current stock price of 71.95.
Analyst Consensus: Buy
* Price targets were last updated on Dec 17, 2024.
Analyst Ratings
The average analyst rating for TransMedics Group stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 6 | 6 | 5 | 4 | 4 | 4 |
| Hold | 2 | 2 | 3 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 5, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $116 → $75 | Buy → Hold | Downgrades | $116 → $75 | +4.24% | Dec 17, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $110 → $90 | Buy | Maintains | $110 → $90 | +25.09% | Dec 11, 2024 |
| Baird | Baird | Buy Maintains $150 → $120 | Buy | Maintains | $150 → $120 | +66.78% | Dec 11, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 11, 2024 |
Financial Forecast
Revenue This Year
438.81M
from 241.62M
Increased by 81.61%
Revenue Next Year
537.62M
from 438.81M
Increased by 22.52%
EPS This Year
0.99
from -0.77
EPS Next Year
1.49
from 0.99
Increased by 50.67%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 458.3M | 603.0M | 708.6M | |||
| Avg | 438.8M | 537.6M | 650.1M | |||
| Low | 416.4M | 498.5M | 594.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 89.7% | 37.4% | 31.8% | |||
| Avg | 81.6% | 22.5% | 20.9% | |||
| Low | 72.3% | 13.6% | 10.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.12 | 1.79 | 2.89 |
| Avg | 0.99 | 1.49 | 2.33 |
| Low | 0.81 | 1.12 | 1.63 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 80.2% | 93.5% |
| Avg | - | 50.7% | 56.3% |
| Low | - | 12.8% | 9.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.